Yahoo Web Search

Search results

1. • 

     The Key to Finding Predictive Biomarkers in Metastatic Renal Cell Carcinoma?

     MedPage Today· 2 days ago

     Identification of clinically meaningful, reproducible, and widely available prognostic and, more...

2. • 

     David Braun, MD, PhD, on Biomarkers in Renal Cell Carcinoma

     MedPage Today· 2 days ago

     For patients with metastatic renal cell carcinoma (RCC), there are as yet no reliable biomarkers to...

3. • 

     BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial

     Clinical Trials Arena via Yahoo Finance· 2 days ago

     Yervoy is a cytotoxic T-lymphocyte associated protein 4 (CTLA-4) inhibiting monoclonal antibody and...

4. • 

     HUTCHMED begins trial of combination therapy for pancreatic ductal adenocarcinoma

     Clinical Trials Arena via Yahoo Finance· 21 hours ago

     In December last year, Hutchmed finished enrolling subjects in a Phase II/III clinical trial of...

5. • 

     Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates

     Zacks via Yahoo Finance· 5 days ago

     Iovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...

6. • Wedbush Boosts Janux Therapeutics (NASDAQ:JANX) Price Target to $74.00

     ETF DAILY NEWS· 4 days ago

     Janux Therapeutics (NASDAQ:JANX – Free Report) had its target price increased by Wedbush from $53.00 to $74.00 in a research note published on Wednesday morning, Marketbeat reports. The brokerage ...

7. • 

     Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?

     Motley Fool via Yahoo Finance· 3 days ago

     Its two most important markets are renal cell carcinoma (RCC, a type of kidney cancer) and...

8. • HC Wainwright Reiterates “Buy” Rating for Iovance Biotherapeutics (NASDAQ:IOVA)

     ETF DAILY NEWS· 3 days ago

     Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research report issued to clients and investors on Friday ...

9. • Benjamin F. Edwards & Company Inc. Buys Shares of 542 BeiGene, Ltd. (NASDAQ:BGNE)

     ETF DAILY NEWS· 2 days ago

     Benjamin F. Edwards & Company Inc. purchased a new stake in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities ...

10. • Q2 2024 EPS Estimates for Janux Therapeutics, Inc. Cut by William Blair (NASDAQ:JANX)

      ETF DAILY NEWS· 5 days ago

      Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Stock analysts at William Blair reduced their Q2 2024 earnings estimates for shares of Janux Therapeutics in a research note issued on ...